Trudhesa for Migraine: DHE Nasal Spray and Safety

Trudhesa is a prescription nasal spray containing dihydroergotamine, often shortened to DHE. It treats migraine attacks with or without aura in adults; it does not prevent future attacks. [2] Its delivery device directs the medicine to the upper nasal space. [3]

A nasal treatment can be helpful to discuss when tablets are difficult to use. DHE also has substantial precautions. Before considering Trudhesa, the clinician needs to review circulation and heart health, every other medicine you take, and a clear plan for treating an attack safely.

How DHE fits into migraine treatment

DHE is an ergot medicine. It affects serotonin-related signaling and can narrow blood vessels. That action helps explain why vascular history and medication combinations matter. [2] Trudhesa is different from a triptan nasal spray or a nasal gepant; sharing a route does not make the medicines interchangeable.

International Headache Society recommendations reserve ergot derivatives for situations in which other recommended acute treatments with better safety profiles have failed. [5] A difficult attack history can justify reviewing additional options, but it does not prove that DHE is appropriate or that it will work.

When you describe a previous treatment, explain whether it never helped, helped only partly, wore off, caused side effects, or could not be taken because of vomiting. These details give the clinician a more useful starting point than the word “failure.”

Why the nasal route deserves its own discussion

Nonoral formulations are among the options for people who vomit early during migraine. Selection depends on availability, preference, and medical history. [5] Trudhesa's device is intended to place DHE in the upper nasal space. [3] It is a drug and device combination, so preparation and technique are part of using it correctly.

Consider what an attack is like in your actual day. Can you recognize the headache phase? Would you be able to prepare a device while nauseated? Is there a private place to keep the medicine accessible? These practical questions help you and the clinician assess whether a proposed treatment is usable, as well as medically suitable.

What Trudhesa research does and does not show

The STOP 301 study evaluated the formulation then called INP104 over 24 weeks, with a longer extension for some participants. Its main purpose was safety and tolerability. It was open label: patients and investigators knew which treatment was being used. Reported symptom improvements were exploratory findings, rather than the result of a blinded comparison with another treatment. [4]

That distinction matters when reading claims about speed, lasting relief, or treatment late in an attack. The study can inform a discussion, but it does not establish that Trudhesa outperforms every alternative. It cannot guarantee that a particular person's attack will end or that a prior medication problem will be solved.

The boxed interaction warning

Trudhesa carries a boxed warning: combining DHE with strong CYP3A4 inhibitors can dangerously restrict blood flow to the brain or limbs. These combinations are contraindicated. [7] Examples include ritonavir, clarithromycin, and certain antifungals. [2] A short course of another medicine can matter as much as a daily prescription.

Do not take Trudhesa within 24 hours of a triptan or another ergot-type medicine; the separation applies in either direction. [1] Tell a pharmacist about Trudhesa before starting a new prescription, including treatment for an infection. Bring the exact name and the time of the last dose of any attack medicine.

Nonprescription cold products, nicotine, and other medicines also warrant review. [2] Do not assume that an over-the-counter product is compatible. Ask for a written list of prohibited combinations and the approved backup plan for an attack.

Who needs particular safety assessment?

Contraindications include ischemic heart disease or coronary spasm, uncontrolled high blood pressure, peripheral arterial disease, sepsis, use after vascular surgery, severe kidney or liver impairment, ergot allergy, and concurrent vasoconstrictors. Cardiovascular evaluation is recommended before starting; some patients need a supervised first dose. [1] Trudhesa is not indicated for hemiplegic or basilar migraine. An online discussion may lead to in-person assessment before a treatment decision.

DHE should be avoided during pregnancy because of the risk of preterm labor. Do not breastfeed during treatment or for three days after the last use; discuss feeding plans with your clinician. [2] Tell the clinician about pregnancy plans before starting.

Chest pain, stroke-like symptoms, or painful, unusually cold or discolored limbs require urgent medical evaluation. Stop the medicine and seek help rather than assuming these symptoms are part of migraine. [7]

Prepare an attack plan and follow-up record

The manufacturer offers a device demonstration. Review it before the first attack you plan to treat, and ask a pharmacist to clarify anything uncertain. [6] Your instructions should address preparation, use, disposal, repeat-use limits, and what to do if symptoms continue. One Trudhesa dose is two sprays: one in each nostril. A repeat dose must be at least one hour later. The labeled maximum is two doses in 24 hours and three doses in seven days. Use it exactly as prescribed. [1]

• List your headache days and days on which you use any acute medicine.
• Record treatment times so the clinician can assess medication sequencing.
• Note relief, ability to resume activities, and any later return of pain.
• Describe nasal irritation, nausea, or any other symptom after treatment.
• Bring all prescriptions, supplements, and cold medicine names to follow-up.
• Ask when to call the practice and which symptoms require emergency care.

Frequent use of acute medicines should prompt a review of the overall plan. The label warns about medication-overuse headache. [1] Read medicines for attacks versus prevention before discussing how an attack treatment and prevention could fit together.

Frequently asked questions about Trudhesa

Can I use it after my triptan has not helped?

Not within 24 hours of that triptan. [2] Ask for a backup plan in advance. Persistent pain does not make a prohibited combination safe.

Is Trudhesa a daily preventive medicine?

No. It is an acute treatment. [3] If you often need rescue treatment or miss activities despite it, bring that pattern to follow-up rather than increasing use yourself.

Discussing Trudhesa with TeleHeadache

TeleHeadache offers online assessment for eligible adults age 18 and older who are physically located in Florida and may prescribe when clinically appropriate. Reviewing a DHE option includes deciding whether additional examination or cardiovascular assessment is needed. Pharmacy medication costs are separate from clinical care costs. Coverage, access, and the final prescription depend on your individual situation.

Official medication information and further reading

Official Trudhesa website · Trudhesa on Drugs.com · Drugs.com

Use the current U.S. prescribing information and your own prescription instructions when discussing this medicine with your clinician or pharmacist.

Educational information supports a discussion with your clinician and does not replace individualized medical evaluation. Medication choice and prescribing require clinical review.